[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100507246":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":17,"responsibleParty":39,"collaborators":7,"id":41,"slug":7,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":7,"eligibilityCriteria":45,"healthyVolunteers":46,"sex":47,"minAge":7,"maxAge":7,"enrollmentInfo":48,"targetDuration":51,"studyType":52,"phases":7,"briefSummary":53,"conditions":54,"keywords":56,"overallStatus":20,"whyStopped":7,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},{"fullName":5,"class":6},"Magdi Yacoub Heart Foundation","OTHER",null,[9,13],{"name":10,"role":11,"phone":7,"phoneExt":7,"email":12},"Magdi H Yacoub, FRS OM","CONTACT","m.yacoub@imperial.ac.uk",{"name":14,"role":11,"phone":15,"phoneExt":7,"email":16},"Shehab M Anwer, MBBCh., MRes","+41788816333","shehabanwer@gmail.com",[18],{"facility":19,"status":20,"city":21,"state":7,"zip":7,"country":22,"cosmosGeoPoint":23,"geoPoint":28,"contacts":29},"Aswan Heart Centre - Magdi Yacoub Heart Foundation","RECRUITING","Aswān","Egypt",{"type":24,"coordinates":25},"Point",[26,27],32.89942,24.09082,{"lat":27,"lon":26},[30,34,36],{"name":31,"role":11,"phone":32,"phoneExt":7,"email":33},"Ahmed M ElGuindy, MD, MRCP","+201001615151","ahmed_elguindy@hotmail.com",{"name":35,"role":11,"phone":15,"phoneExt":7,"email":16},"Shehab M Anwer, MBBCh, MRes, PhD",{"name":37,"role":38,"phone":7,"phoneExt":7,"email":7},"Magdi H Yacoub, OM FRS","PRINCIPAL_INVESTIGATOR",{"type":40,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100507246",false,"NCT05884892","Egyptian Hypertrophic Cardiomyopathy Program","Inclusion Criteria:\n\n* All patients diagnosed with hypertrophic cardiomyopathy (index patients) who are willing and consented to participate in the registry.\n* All family members of index patients who are willing and consented to participate in the registry.\n\nExclusion Criteria:\n\n* Refusal to consent to participate in the registry program.",true,"ALL",{"count":49,"type":50},2000,"ESTIMATED","10 Years","OBSERVATIONAL","Egyptian HCM program aims at defining incidence, severity, phenotype, genotype and determinants of the disease in Egypt, and providing state-of-the-art treatment strategies including medical, surgical and interventional procedures which are patient- and disease-specific.",[55],"Hypertrophic Cardiomyopathy",[57,58,55,59,60,61],"HCM","HOCM","Familial Hypertrophic Cardiomyopathy","Hypertrophic Cardiomyopathy with Genetic Marker","Hypertrophic Obstructive Cardiomyopathy","2023-05-23",{"date":64,"type":65},"2023-06-01","ACTUAL",{"date":67,"type":65},"2014-01-01",{"date":69,"type":50},"2030-01-01",{"name":5,"class":6},1]